Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 17:22 (577 d 14:46 ago) – Posting: # 20812
Views: 3,633

» Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.

And all this at the moment is a offense against the law.

Complete thread:

Activity
 Admin contact
21,523 posts in 4,499 threads, 1,523 registered users;
online 8 (2 registered, 6 guests [including 2 identified bots]).
Forum time: Wednesday 09:09 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5